CN1929882A - Vegf受体酪氨酸激酶抑制剂涂布的支架 - Google Patents
Vegf受体酪氨酸激酶抑制剂涂布的支架 Download PDFInfo
- Publication number
- CN1929882A CN1929882A CNA2005800075100A CN200580007510A CN1929882A CN 1929882 A CN1929882 A CN 1929882A CN A2005800075100 A CNA2005800075100 A CN A2005800075100A CN 200580007510 A CN200580007510 A CN 200580007510A CN 1929882 A CN1929882 A CN 1929882A
- Authority
- CN
- China
- Prior art keywords
- support
- tyrosine kinase
- receptor tyrosine
- vegf
- kinase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55915004P | 2004-04-02 | 2004-04-02 | |
US60/559,150 | 2004-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1929882A true CN1929882A (zh) | 2007-03-14 |
Family
ID=34962708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800075100A Pending CN1929882A (zh) | 2004-04-02 | 2005-04-01 | Vegf受体酪氨酸激酶抑制剂涂布的支架 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1735026A1 (fr) |
JP (1) | JP2007530633A (fr) |
KR (1) | KR20070004795A (fr) |
CN (1) | CN1929882A (fr) |
AU (1) | AU2005229566A1 (fr) |
BR (1) | BRPI0509566A (fr) |
CA (1) | CA2559756A1 (fr) |
WO (1) | WO2005094916A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101925451B (zh) * | 2008-01-23 | 2013-08-21 | 诺瓦提斯公司 | 涂布有机硅水凝胶的方法 |
TWI482757B (zh) * | 2013-10-07 | 2015-05-01 | Luminescence Technology Corp | Vegf-2/3受體及蛋白質酪胺酸激酶抑制劑及其醫藥用途 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8057815B2 (en) | 2004-04-19 | 2011-11-15 | Portola Pharmaceuticals, Inc. | Methods of treatment with Syk inhibitors |
DK3103448T3 (da) * | 2006-09-26 | 2019-10-07 | Novartis Ag | Farmaceutiske sammensætninger, der omfatter en S1P-modulator |
EP2268812A1 (fr) * | 2008-04-09 | 2011-01-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Inhibiteurs de stim1 pour le traitement de troubles cardiovasculaires |
WO2011089152A1 (fr) | 2010-01-20 | 2011-07-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et composition pharmaceutique pour la préservation de l'intégrité de la barrière cellulaire de l'endothélium vasculaire |
WO2012110843A1 (fr) | 2011-02-18 | 2012-08-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et compositions pharmaceutiques pour promouvoir la fibrinolyse et la thrombolyse |
WO2013024022A1 (fr) | 2011-08-12 | 2013-02-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et compositions pharmaceutiques pour traiter l'hypertension pulmonaire |
WO2013050441A1 (fr) | 2011-10-05 | 2013-04-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés et composition pharmaceutique pour l'inhibition ou la prévention de l'agrégation des plaquettes |
WO2013054153A1 (fr) | 2011-10-11 | 2013-04-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Composés de nutline pour une utilisation dans le traitement de l'hypertension artérielle pulmonaire |
US20150105329A1 (en) | 2012-03-26 | 2015-04-16 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ Damage |
JP6302936B2 (ja) | 2013-01-14 | 2018-03-28 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 心臓保護のための方法及び医薬組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050125054A1 (en) * | 2000-12-22 | 2005-06-09 | Avantec Vascular Corporation | Devices delivering therapeutic agents and methods regarding the same |
JP2005523050A (ja) * | 2002-02-06 | 2005-08-04 | オーバス メディカル テクノロジーズ インク. | 内皮細胞の接着および分化を促進するコーティングを有する医療用デバイス |
JP2005533604A (ja) * | 2002-07-25 | 2005-11-10 | アバンテック バスキュラー コーポレーション | 治療薬を送達する装置とこれに関する方法 |
BRPI0414604A (pt) * | 2003-09-23 | 2006-11-07 | Novartis Ag | combinações de um inibiddor do receptor de vegf com outros agentes terapêuticos |
-
2005
- 2005-04-01 CA CA002559756A patent/CA2559756A1/fr not_active Abandoned
- 2005-04-01 JP JP2007505513A patent/JP2007530633A/ja active Pending
- 2005-04-01 BR BRPI0509566-2A patent/BRPI0509566A/pt not_active Application Discontinuation
- 2005-04-01 AU AU2005229566A patent/AU2005229566A1/en not_active Abandoned
- 2005-04-01 WO PCT/EP2005/003459 patent/WO2005094916A1/fr not_active Application Discontinuation
- 2005-04-01 EP EP05716501A patent/EP1735026A1/fr not_active Withdrawn
- 2005-04-01 KR KR1020067020310A patent/KR20070004795A/ko not_active Application Discontinuation
- 2005-04-01 CN CNA2005800075100A patent/CN1929882A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101925451B (zh) * | 2008-01-23 | 2013-08-21 | 诺瓦提斯公司 | 涂布有机硅水凝胶的方法 |
TWI482757B (zh) * | 2013-10-07 | 2015-05-01 | Luminescence Technology Corp | Vegf-2/3受體及蛋白質酪胺酸激酶抑制劑及其醫藥用途 |
Also Published As
Publication number | Publication date |
---|---|
CA2559756A1 (fr) | 2005-10-13 |
WO2005094916A1 (fr) | 2005-10-13 |
KR20070004795A (ko) | 2007-01-09 |
EP1735026A1 (fr) | 2006-12-27 |
AU2005229566A1 (en) | 2005-10-13 |
JP2007530633A (ja) | 2007-11-01 |
BRPI0509566A (pt) | 2007-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1929882A (zh) | Vegf受体酪氨酸激酶抑制剂涂布的支架 | |
CN1326577C (zh) | N-{5-[4-(4-甲基-哌嗪-1-基甲基)-苯甲酰氨基]-2-甲基苯基}-4-(3-吡啶基)-2-嘧啶-胺涂层的支架 | |
US20030170287A1 (en) | Drug delivery systems for the prevention and treatment of vascular diseases | |
CN103143069B (zh) | 用于整合入医疗装置的疏水性改善的药物 | |
KR20070015113A (ko) | 제약 조성물 | |
CN1714085A (zh) | 药物递送系统 | |
CN101081316A (zh) | 一种新型药物洗脱支架 | |
CN1723018A (zh) | 用于治疗支架狭窄的微管稳定剂 | |
US20130123306A1 (en) | Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease | |
CN100571793C (zh) | 药物组合物 | |
AU2009201507A1 (en) | Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof | |
AU2007200756A1 (en) | Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |